Claxton K - Search Results

1

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.

Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, Devlin N, Smith PC, Sculpher M. Claxton K, et al. Health Technol Assess. 2015 Feb;19(14):1-503, v-vi. doi: 10.3310/hta19140. Health Technol Assess. 2015. PMID: 25692211 Free PMC article.

2

Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application.

Sculpher M, Fenwick E, Claxton K. Sculpher M, et al. Among authors: claxton k. Pharmacoeconomics. 2000 May;17(5):461-77. doi: 10.2165/00019053-200017050-00005. Pharmacoeconomics. 2000. PMID: 10977388 Review.

3

Introduction. Bayesian approaches to technology assessment and decision making.

Luce BR, Shih YC, Claxton K. Luce BR, et al. Among authors: claxton k. Int J Technol Assess Health Care. 2001 Winter;17(1):1-5. doi: 10.1017/s0266462301104010. Int J Technol Assess Health Care. 2001. PMID: 11329837 No abstract available.

4

Bayesian value-of-information analysis. An application to a policy model of Alzheimer's disease.

Claxton K, Neumann PJ, Araki S, Weinstein MC. Claxton K, et al. Int J Technol Assess Health Care. 2001 Winter;17(1):38-55. doi: 10.1017/s0266462301104058. Int J Technol Assess Health Care. 2001. PMID: 11329844

5

Representing uncertainty: the role of cost-effectiveness acceptability curves.

Fenwick E, Claxton K, Sculpher M. Fenwick E, et al. Among authors: claxton k. Health Econ. 2001 Dec;10(8):779-87. doi: 10.1002/hec.635. Health Econ. 2001. PMID: 11747057

6

Pre-operative optimisation employing dopexamine or adrenaline for patients undergoing major elective surgery: a cost-effectiveness analysis.

Fenwick E, Wilson J, Sculpher M, Claxton K. Fenwick E, et al. Among authors: claxton k. Intensive Care Med. 2002 May;28(5):599-608. doi: 10.1007/s00134-002-1257-y. Epub 2002 Mar 26. Intensive Care Med. 2002. PMID: 12029409 Free article. Clinical Trial.

7

A rational framework for decision making by the National Institute For Clinical Excellence (NICE).

Claxton K, Sculpher M, Drummond M. Claxton K, et al. Lancet. 2002 Aug 31;360(9334):711-5. doi: 10.1016/S0140-6736(02)09832-X. Lancet. 2002. PMID: 12241891

8

A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme.

Claxton K, Ginnelly L, Sculpher M, Philips Z, Palmer S. Claxton K, et al. Health Technol Assess. 2004 Jul;8(31):1-103, iii. doi: 10.3310/hta8310. Health Technol Assess. 2004. PMID: 15248937 Free article.

9

Review of guidelines for good practice in decision-analytic modelling in health technology assessment.

Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J. Philips Z, et al. Among authors: claxton k. Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. doi: 10.3310/hta8360. Health Technol Assess. 2004. PMID: 15361314 Free article. Review.

10

Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.

Claxton K, Sculpher M, McCabe C, Briggs A, Akehurst R, Buxton M, Brazier J, O'Hagan T. Claxton K, et al. Health Econ. 2005 Apr;14(4):339-47. doi: 10.1002/hec.985. Health Econ. 2005. PMID: 15736142 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters